The purpose of this study was to compare the quality of life (QOL) of male and female allogeneic BMT recipients. One hundred and nine BMT patients participated in this cross-sectional survey and completed the following instruments: Functional Assessment of Cancer Treatment (FACT-BMT version 3), shortened version of Profile of Mood States (POMS), MOS Survey of Social Support, and A Brief Measure of Social Support (SSQ6). Independent of the time post-BMT, perceived physical well-being, age at BMT, and education, females reported worse emotional well-being and more fatigue than males. Females also indicated more tiredness and less quality sleep. Males were found to experience less satisfaction with social support regardless of marital status. On the other hand, married males were more satisfied with their sexual life, more interested in sexual relationships, and more sexually active compared to married females. However, no significant differences between males and females were found in terms of overall physical, functional, and social well-being assessed by the FACT-BMT. The present results indicated that important gender differences exist among allogeneic BMT recipients which need to be addressed when designing post-treatment intervention programs for BMT recipients. Bone Marrow Transplantation (2001) 28, 503-509.
being, referring not only to the lack of emotional distress, but also to the presence of positive well-being or happiness in life; and (4) social well-being, encompassing activities with and support from family and friends. 2 Although the impact of BMT has been increasingly examined, relatively little is known about potential genderassociated differences in QOL that may exist in this population. According to Bird and Rieker, 3 sampling and statistical techniques that simply adjust or control the differences in men's and women's overall health response to a given treatment fail to tell us whether the results are the same for males and females. Additional subgroup analyses by gender are needed to reveal whether or not the results are similar for male and female subjects.
The results of previous studies are somewhat contradictory. There is evidence, for example, that women experience more sleeping problems, 4 ,5 greater problems with sexuality, 4, 6, 7 poorer overall QOL, 4 higher prevalence of psychiatric morbidity, 4 and more negative affect 8 than men. On the other hand, female BMT-recipients have been reported to perceive their current health better than male recipients. 9 Finally, a number of studies report no significant gender differences on QOL. 10, 11 Similarly, contradictory results have been found in studies concerning other cancer patients. Some studies have shown a significantly higher level of emotional distress and more problems in psychosocial adjustment in females than in males, 12, 13 whereas others have found no significant gender differences in psychological responses. 14, 15 There is also evidence suggesting that men's psychosocial adjustment after a diagnosis of cancer 16, 17 may be poorer than that of women. Further, it has been found that QOL and psychosocial distress improve among the BMT-patients with the passage of time, especially during the first 3 years. 4 In their prospective study, Syrjala et al 7 found sexual problems particularly among female BMT-patients, also 3 years after the BMT.
To some extent, the variability in previous study findings may be due to a lack of agreement on the measures used to assess QOL, making comparisons between studies difficult. Previous QOL studies among BMT-patients have also been criticised for pooling and comparing patients treated with different treatment regimes. 18 Among the normal Finnish population, men and women estimated their health status very similarly and no significant gender differences were found. However, there were differences in psychosomatic symptoms. In comparison to males, females perceived more sleeping problems, tiredness, depression, headache, nervousness, as well as difficulties with memory and concentration than males. 19 Knowledge about differences in QOL after BMT in males and females might have important implications for the design and development of interventions intended to minimize the psychosocial problems experienced by transplant patients. In the light of the above, the aim of the present study was to compare the QOL of male and female recipients of allogeneic BMT, using psychometrically wellestablished measures. In addition, gender differences were examined in associations between post-BMT QOL and a number of factors that have been found to be related to QOL in prior research. These included the relationship between post-BMT QOL and cGVHD, 9,10 total body irradiation (TBI) received during conditioning, 20 time post BMT, 4, 6, 10 age at BMT, 4, 6, 10 education, 4, 6 and perceived social support. 21 Our aim was to compare QOL and factors associated with QOL among the sexes in the groups of patients in and over 3 years post-BMT.
Materials and methods

Patients
One hundred and sixty-four allogeneic BMT-patients transplanted between 1988 and 1997 at Helsinki University Central Hospital were mailed a letter describing the study, and a consent form. The inclusion criteria were a minimum follow-up time of 4 months, age over 18 years, and no basic disease relapse. One hundred and thirty-two patients were willing to participate, and a packet of questionnaires was sent to them. One hundred and nine patients (67%) filled out and returned the questionnaire. The questionnaires were returned to an independent research center not involved in the treatment of the patients. The study was reviewed and approved by the Ethics Committee of Helsinki University Central Hospital. Table 1 shows the sociodemographic and treatment characteristics of the male and female participants. Conditioning consisted of fractionated total body irradiation (total dose 12 Gy given in six fractions for 5 days) and cyclophosphamide 120 mg/kg in 91 patients; 16 patients received busulphan 16 mg/kg and cyclophosphamide 120 mg/kg and two patients cyclophosphamide 200 mg/kg only. Ninenty-three patients received an allogeneic graft from an HLA-identical sibling donor, one from a syngeneic donor, and 15 from a matched unrelated donor. Hormone replacement therapy was given to 56 (92%) female patients.
Methods
The measures completed by the participants included the shortened version of the Profile of Mood States (POMS), 22, 23 the Functional Assessment of Cancer Therapy BMT-version (FACT-BMT version 3), 24 ,25 the Activities of Daily Living Scale (ADL), 26 MOS Survey of Social Support, 27 and A Brief Measure of Social Support (SSQ6). 28 High values on all the measures, except on the POMS scales indicate good QOL. The methods are described in detail with internal consistency measures (Crohnbach's alphas) in the study of Heinonen et al. 29 Descriptive data (age, education, marital status, working status, number of children, family income, diagnosis) were assessed following Finnish epidemiological studies. 30 Additional information of the patient's functional status at the time of the study participation was gathered from the medical records in the form of the scores on the Karnofsky performance scale 31 (estimated by physicians).
Statistics
Statistical analyses using the Statistical Package for the Social Sciences (SPSS) were performed to test the association between demographic-, disease-, and transplantrelated variables and QOL dimensions. The one-way analysis of variance was used to test the differences between the male and female recipients in the mean QOL ratings. Univariate analyses of covariance (ANCOVA) were used to detect the main effects of gender on the QOL domains with the effects of the follow-up time, age at BMT, marital status, cGVHD, total body irradiation received in pre-BMT conditioning, perceived physical well-being, and education taken into account as covariates. Pearson's correlation coefficients were calculated to examine associations between the QOL dimensions and the follow-up time, current age, age at BMT, education, marital status, availability of social support and satisfaction with social support.
2
-tests were conducted to analyze gender differences in the categorical variables.
To see whether there were any differences between the sexes in a passage of time (see Refs 4 and 7), patients were stratified into two groups according to the length of time after their BMT: I group р36 months, n = 47; II group Ͼ36 months, n = 62. The probability level required for statistical significance was set at 0.05.
Results
Respondents vs non-respondents
The non-respondents in the study (n = 55) were compared to the subjects using the following variables: age, age at BMT, time since BMT, score on the Karnofsky performance scale, 31 gender, and diagnosis. Compared to the respondents, the non-respondents had a significantly longer follow-up time (means; respondents = 54.5 months, nonrespondents = 76.1 months, P Ͻ 0.001) and a younger age at BMT (means; respondents = 38.1 years, non-respondents = 34.1 years, P Ͻ 0.05). The non-respondents and the respondents did not differ regarding Karnosfky performance scale and current age. However, the group of nonrespondents included significantly (P Ͻ 0.05) more males (n = 35) than females (n = 20). Regarding current age, age at BMT, time since BMT, and Karnofsky performance scale, the male and female non-respondents did not differ from each other. 
Gender differences in sociodemographic and treatment characteristics
There were no statistically significant differences between the groups regarding diagnoses, age at BMT, current age, prior conditioning treatment, existence of cGVHD, donor type, follow-up time, marital status, educational level or current occupational status. Table 2 shows the mean values for the male and female BMT recipients on the QOL dimensions. Scores on the FACT emotional well-being and the BMT scales indicated that the female recipients experienced significantly lower well-being compared to the males. The POMS fatigue scale scores indicated that, on average, the females experienced more fatigue than the males. The main effects of gender remained significant in the models of univariate analyses, when the follow-up time, age at BMT, education, perceived physical well-being, cGVHD, and TBI were taken in the models as covariates. The main effects of gender on the FACT emotional well-being scale (F = 4.7, P Ͻ 0.05, Eta 2 = 0.06), on the BMT scale (F = 10.4, P Ͻ 0.01, Eta 2 = 0.06), and on the POMS fatigue scale were statistically significant (F = 5.3, P Ͻ 0.05, Eta 2 = 0.05).
Gender-dependent differences in QOL dimensions
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The male respondents were less satisfied with received social support as measured by the SSQ6. When marital status was taken into account in the univariate analyses, the gender differences persisted (the main effect of gender F = 4.4, P Ͻ 0.05, Eta 2 = 0.04). Regardless of marital status, the males were less satisfied with their social support.
On the FACT physical, functional, and social well-being scales, however, there were no statistically significant gender differences. Neither the ADL-scale nor the Karnofsky performance scale showed statistically significant differences between sexes. The two groups did not differ on the following POMS scales: depression, anxiety, confusion, anger, or total mood disturbance. Furthermore, no differences were found in terms of availability of social support as measured by the MOS, neither on any of the subscales nor on the overall support scale.
Tiredness and sleeping problems after BMT
Comparisons of the quality of sleep and tiredness were based on FACT items: 'I get tired easily' (FACT 42) and 'I am sleeping well' (FACT 31). In group I with 3 years or less since BMT, 30% of the male recipients, but 23% of the female recipients indicated high (very much/much) levels of tiredness. The mean scores between male (mean = 2.1, s.d. = 1.24) and female (mean = 2.00, s.d. = 1.03) recipients did not differ (F = 0.24, P = 0.88). However, in group II over 3 years since BMT, the percentage of males reporting high levels of tiredness had decreased to 4%, while the percentage of females reporting high levels of tiredness had increased to 34%. In this group, 87% of the males and 48% of the females reported low (not at all/a little bit) levels of tiredness. The mean difference between the males (mean = 0.8, s.d. = 0.9) and the females (mean = 1.7, s.d. = 1.4) was statistically significant (F = 10.1, P Ͻ 0.01).
The same phenomenon can be seen when assessing sleep quality. Among the male subjects, 79% of those with 3 years or less post-BMT reported very good/good sleep quality, in comparison to 96% of those more than 3 years post-BMT. Among the female BMT-recipients, there were no differences in sleep quality between the short-and longterm follow-up groups (68% in both groups). The mean difference between the males (mean = 3.0, s.d. = 1.1) and the females (mean = 2.9, s.d. = 1.1) was not statistically significant in the group of 3 years or less post-BMT. However, in the group of more than 3 years post-BMT, the mean difference in sleep quality between the males (mean = 3.6, s.d. = 0.56) and the females (mean = 3.0, s.d. = 1.1) was statistically significant (F = 7.6, P Ͻ 0.01).
Sexual satisfaction and sexual activity among married (/living with mate) male and female BMT-recipients
The categorical results of the analyses of the FACT items: 'How satisfied you are with your sexual life' and 'Have you been sexually active during the past year' revealed some significant gender differences. Only 6% of the married males reported low levels of sexual satisfaction (not at all/a little bit satisfied) compared to 28% of the married females. Consistent with this finding, 69% of the married males reported high levels of sexual satisfaction (very much/much satisfied) compared to 42% of the married females ( 2 = 7.5, df = 2, P Ͻ 0.05). Married males were also more active sexually, with 81% of them sexually active compared to 58% of the females ( 2 = 4.95, P Ͻ 0.05). To examine further the main effect of gender in the group of married participants, a univariate analysis of covariance was performed with perceived physical well-being, followup time, age at BMT, education, and cGVHD as covariates. The main effect of the model was statistically significant (F = 6.1, P Ͻ 0.01, r 2 = 0.33), and also the main effect of gender yielded significance (F = 8.3, P Ͻ 0.01, Eta 2 = 0.07), females indicating less sexual satisfaction.
To analyze the impact of the follow-up time on perceived sexual satisfaction, we compared the mean scores of perceived sexual satisfaction between married males and females stratified in groups I and II according to the followup time. The mean difference between the males (mean = 2.1, s.d. = 1.0) and the females (mean = 1.8, s.d. 1.4) in group I was not statistically significant (F = 0.3, P = 0.6). However, in group II, the males (mean = 3.1, s.d. = 0.9) perceived their sexual satisfaction better compared to the females (mean = 2.3, s.d. = 1.3) (F = 6.6, P = 0.01). Table 3 presents the correlation coefficients between the follow-up time, cGVHD, TBI, current age, age at BMT, education, marital status, satisfaction with social support, availability of social support, the FACT scales, and the POMS TMD-scale. The perceived physical well-being of both genders was significantly related to follow-up time, indicating better physical well-being with the passage of time. In the group of male recipients, emotional well-being, sleep quality, and tiredness also proved to be significantly associated with follow-up interval. Marital status was associated with social well-being, with married males showing greater social well-being.
Factors related to QOL dimensions among male and female recipients
In the group of female recipients, older age at BMT was associated with worse physical and functional well-being, and severity of cGHVD was associated with poorer emotional well-being. Poorer education among the females was related to tiredness. Among the male recipients, there was no statistically significant relationship between education and any of the assessed dimensions of well-being. Among female recipients, marital status was unrelated to social support. For both groups, satisfaction with social support was associated with total mood disturbance scores, indicating that recipients who were not satisfied with perceived social support also experienced more mood disturbances. Age at BMT was associated with sexual satisfaction among married (living with mate) male and female recipients, with older age at BMT associated with lower sexual well-being. Among the male subjects, a longer follow-up time and less severe cGVHD were related to higher satisfaction with sexual life. Among the females, older current age was associated with lower satisfaction with sexual life. TBI was not associated with any of the well-being dimensions among males or females. Table 3 Correlation coefficients between the well-being variables and the follow-up time, cGVHD, TBI, current age, age at BMT, education, marital status, satisfaction with social support, and availability of social support among BMT-recipients 
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Discussion
The present study compared physical, functional, emotional, and social well-being between males and females in a representative sample of allogeneic BMTrecipients. The results indicated that female BMT-recipients experienced greater fatigue and perceived their emotional well-being as worse than male survivors. Males were also more likely to report good sleep quality and less tiredness when compared to females. Similarly, married male BMT-recipients were found to report greater satisfaction with their sexual life when compared to married female subjects. Among male subjects, emotional well-being, sleep quality, tiredness, and sexual satisfaction were found to be related to follow-up interval, while, among female BMTrecipients, the follow-up interval was unrelated to these factors.
Andrykowski et al 5 suggested that sleep and energy difficulties may become chronic among BMT-recipients. Their data did not show any strong correlation between the incidence and severity of sleep and energy problems and the passage of time post-BMT. In their study, the presence of sleep problems was associated with older age at BMT and female gender. In agreement with their findings, the present data indicated that older age at BMT has an adverse impact on sleep quality, but only among female recipients. The presence of cGVHD has also been reported to affect adversely QOL. 4, 6, 8, 10, 32 In the present sample, the grade of cGVHD was significantly associated with lower emotional well-being among the female recipients and with less sexual satisfaction among the married male subjects. In an earlier study, 22 an increased total dose of TBI was found to be
Bone Marrow Transplantation associated with a poorer post-BMT physical status. We could not find any association between QOL dimensions and fractionated 12 Gy TBI among the gender groups.
In the present study, 6% of the males and 28% of the females who were living with their mate reported low levels of satisfaction with their sexual life. Among the Finnish general population, 4% of the males and 6% of the females considered their sexual life unsatisfactory. 33 The present results indicate that sexual satisfaction among the male BMT-recipients appears to be congruent with the level of sexual satisfaction reported by the normal population. Among the female recipients, however, problems regarding sexual satisfaction seem to be markedly more frequent than in the general population. Also Syrjala et al 7 reported more sexual problems among the female recipients 3 years post-BMT. Our results indicate that these problems continue to hamper female recipients' QOL beyond that time period. Interventions to increase the application of hormonal, mechanical, and behavioral methods to moderate sexual difficulties among female BMT-recipients have been suggested. 7 Our study indicated that hormone replacement therapy alone may not be effective enough, considering that in the present study population most of the females had had hormone replacement therapy. Knowing that females are more likely to experience decreased sexual satisfaction after the treatment is important in the pre-treatment consent process, as well as in the post-treatment rehabilitation. This knowledge may also help couples to adjust to BMT, which is a major source of stress under all circumstances.
Regardless of the availability of social support and of marital status, the males were on average less satisfied with their social support. In the social support literature, there is empirical evidence showing that gender differences do emerge when quality rather than quantity of relationships is measured. It has been shown that women report higher quality of relationships compared to their male counterparts. [34] [35] [36] In part, this may be due to the fact that compared to men, women in general appear to be more capable in providing and receiving emotional support. 35 Fife et al 16 found that females benefit more from family support, but males benefit more from support provided by health care professionals. The gender difference in perceived satisfaction with social support found in our study may result from the fact that health care professionals are not as readily available as family members to meet the patient's needs (see Refs 16 and 17) . Males may be in need of augmented and more structured social support offered by the hospital personnel.
Overall, the findings of the present study show that some of the well-established factors found in previous research relating to the QOL of BMT-recipients may have a different impact on female and male survivors. These findings are in terms of guiding the patients' expectations for post-BMT outcome and aftercare needs. Effective preparation in these critical areas should have a positive effect both on shortand long-term BMT-outcome and patient-QOL. 37 Selection bias and its potential impact are concerns when evaluating the results of follow-up studies that focus on psychological and/or emotional functioning. 11 In the present study it was possible to compare the non-respondents and the respondents in terms of possible selection biases. This comparison showed that the non-respondents were characterised by a better functional status, that they had a significantly longer follow-up time, and that they had been significantly younger at the time of their BMT. Male and female non-respondents did not differ regarding current age, age at BMT, time since BMT, and Karnofsky performance scale. Thus, there should be no risk of any significant bias towards poorer QOL among the non-respondents in our study. The patients' reluctance to reveal negative feelings about their treatment or outcomes to the hospital personnel who cared for them is another potential source of bias. In the present investigation, questionnaires were returned to a research center not involved in the patients' treatment. Additional biasing factors, such as those associated with the quality or availability of care resulting from unequal financial resources or insurance coverage, were also minimised in the present investigation due to the uniform availability of treatment, guaranteed by the Finnish public health care system.
The present investigation supports the need to examine further the role of gender when evaluating BMT-patient outcome. This conclusion is buttressed by the illustration that the gender-based differences among the BMTrecipients noted herein exceeded the differences found in the Finnish population. We suggest that these gender-based relationships represent potentially important factors that need to be addressed both in research and clinical practice.
